← Health care and life sciences companies

    4D Molecular Therapeutics: company profile, size and contacts

    4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

    Employees
    101-250
    Founded
    2013
    Total raised
    $595M
    Monthly visits
    8,733

    Company facts

    Website
    4dmoleculartherapeutics.com
    Location
    San Francisco Bay Area, West Coast, Western US
    Employees
    101-250
    Founded
    2013 (13 years ago)
    Categories
    Biotechnology, Genetics
    Company type
    For profit
    Listing
    Public (NASDAQ:FDMT)
    Industry code (NAICS)
    6211 Offices of physicians; 3254 Pharmaceutical and medicine manufacturing
    Industry code (SIC)
    8000 Health services; 2834 Pharmaceutical preparations

    Founders

    • David KirnFounder · 4D Molecular Therapeutics
    • David SchafferFounder · 4D Molecular Therapeutics
    • Theresa JankeFounder · 4D Molecular Therapeutics

    4D Molecular Therapeutics was founded in 2013 by David Kirn, David Schaffer, Theresa Janke.

    Funding

    Total raised
    $595M
    Funding rounds
    6
    Latest round
    Post ipo equity, 2024-02
    Investors
    19
    Lead investors
    2

    Web and app presence

    Monthly website visits
    8,733
    Global traffic rank
    #2,276,809

    How 4D Molecular Therapeutics compares

    • Size: 4D Molecular Therapeutics has more employees than 69% of the 1251 health care and life sciences companies in our directory that report it.
    • Age: 4D Molecular Therapeutics is older than 26% of the 1166 health care and life sciences companies in our directory that report it.
    • Web traffic: 4D Molecular Therapeutics gets more monthly website visits than 74% of the 1233 health care and life sciences companies in our directory that report it.

    1282 health care and life sciences companies are in the directory, 165 of them in the same 101-250 employee range and 43 based in San Francisco Bay Area.

    Growth outlook

    • Trend: Declining
    • Direction: Declining
    • Confidence: High

    4D Molecular Therapeutics experienced a mixed financial performance in 2023, missing earnings expectations. Additionally, an officer sold shares worth $49,900. Despite these setbacks, the company's stock moved 11.1% higher. The company also made significant progress in its gene therapy for severe wet AMD patients, reducing the need for anti-VEGF injections.

    What 4D Molecular Therapeutics says about itself

    “4D Molecular Therapeutics designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions.” 4dmoleculartherapeutics.com

    4D Molecular Therapeutics in short

    4D Molecular Therapeutics is a biotechnology company based in San Francisco Bay Area, with 101-250 employees, founded in 2013. Its founders are David Kirn, David Schaffer and Theresa Janke and it has raised $595 million over 6 rounds.

    Frequently asked questions

    What does 4D Molecular Therapeutics do?
    4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
    When was 4D Molecular Therapeutics founded?
    4D Molecular Therapeutics was founded in 2013, so it is about 13 years old.
    How many employees does 4D Molecular Therapeutics have?
    Crunchbase lists 4D Molecular Therapeutics in the 101-250 employee range.
    Where is 4D Molecular Therapeutics based?
    4D Molecular Therapeutics is listed under San Francisco Bay Area, West Coast, Western US.
    Has 4D Molecular Therapeutics raised funding?
    Crunchbase records $595M raised across 6 funding rounds, most recently post ipo equity in 2024-02.
    How do I find email addresses at 4D Molecular Therapeutics?
    Search the domain 4dmoleculartherapeutics.com with the Inbound Labs Domain Search or Email Finder to see verified contacts and departments. Individual addresses are shown after you sign up.

    Similar companies

    More in Health care and life sciences companies.

    Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.